BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23838731)

  • 1. Clostridium difficile infection in pediatric acute myeloid leukemia: from the Canadian Infections in Acute Myeloid Leukemia Research Group.
    Price V; Portwine C; Zelcer S; Ethier MC; Gillmeister B; Silva M; Schindera C; Yanofsky R; Mitchell D; Johnston DL; Lewis V; Dix D; Cellot S; Michon B; Bowes L; Stobart K; Brossard J; Beyene J; Sung L
    Pediatr Infect Dis J; 2013 Jun; 32(6):610-3. PubMed ID: 23838731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and outcomes associated with severe clostridium difficile infection in children.
    Kim J; Shaklee JF; Smathers S; Prasad P; Asti L; Zoltanski J; Dul M; Nerandzic M; Coffin SE; Toltzis P; Zaoutis T
    Pediatr Infect Dis J; 2012 Feb; 31(2):134-8. PubMed ID: 22031485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between corticosteroids and infection, sepsis, and infectious death in pediatric acute myeloid leukemia (AML): results from the Canadian infections in AML research group.
    Dix D; Cellot S; Price V; Gillmeister B; Ethier MC; Johnston DL; Lewis V; Michon B; Mitchell D; Stobart K; Yanofsky R; Portwine C; Silva M; Bowes L; Zelcer S; Brossard J; Traubici J; Allen U; Beyene J; Sung L
    Clin Infect Dis; 2012 Dec; 55(12):1608-14. PubMed ID: 22955431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, course, and outcome of Clostridium difficile infection in children with hematological malignancies or undergoing hematopoietic stem cell transplantation.
    Salamonowicz M; Ociepa T; Frączkiewicz J; Szmydki-Baran A; Matysiak M; Czyżewski K; Wysocki M; Gałązka P; Zalas-Więcek P; Irga-Jaworska N; Drożyńska E; Zając-Spychała O; Wachowiak J; Gryniewicz-Kwiatkowska O; Czajńska-Deptuła A; Dembowska-Bagińska B; Chełmecka-Wiktorczyk L; Balwierz W; Bartnik M; Zielezińska K; Urasiński T; Tomaszewska R; Szczepański T; Płonowski M; Krawczuk-Rybak M; Pierlejewski F; Młynarski W; Gamrot-Pyka Z; Woszczyk M; Małas Z; Badowska W; Urbanek-Dądela A; Karolczyk G; Stolpa W; Sobol-Milejska G; Zaucha-Prażmo A; Kowalczyk J; Goździk J; Gorczyńska E; Jermakow K; Król A; Chybicka A; Ussowicz M; Kałwak K; Styczyński J
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1805-1812. PubMed ID: 29978303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing community-associated from hospital-associated Clostridium difficile infections in children: implications for public health surveillance.
    Tschudin-Sutter S; Tamma PD; Naegeli AN; Speck KA; Milstone AM; Perl TM
    Clin Infect Dis; 2013 Dec; 57(12):1665-72. PubMed ID: 24046303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and mortality associated with Clostridium difficile infection at a Japanese tertiary care center.
    Honda H; Yamazaki A; Sato Y; Dubberke ER
    Anaerobe; 2014 Feb; 25():5-10. PubMed ID: 24184291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and risk factors for Clostridium difficile infection in children.
    Sandora TJ; Fung M; Flaherty K; Helsing L; Scanlon P; Potter-Bynoe G; Gidengil CA; Lee GM
    Pediatr Infect Dis J; 2011 Jul; 30(7):580-4. PubMed ID: 21233782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
    Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.
    Miller M; Gravel D; Mulvey M; Taylor G; Boyd D; Simor A; Gardam M; McGeer A; Hutchinson J; Moore D; Kelly S
    Clin Infect Dis; 2010 Jan; 50(2):194-201. PubMed ID: 20025526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.
    Garey KW; Dao-Tran TK; Jiang ZD; Price MP; Gentry LO; Dupont HL
    J Hosp Infect; 2008 Oct; 70(2):142-7. PubMed ID: 18723249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile infection in children: epidemiology and risk of recurrence in a low-prevalence country.
    Lo Vecchio A; Lancella L; Tagliabue C; De Giacomo C; Garazzino S; Mainetti M; Cursi L; Borali E; De Vita MV; Boccuzzi E; Castellazzi L; Esposito S; Guarino A
    Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):177-185. PubMed ID: 27696233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile infection in patients with acute myelogenous leukemia and in patients undergoing allogeneic stem cell transplantation: epidemiology and risk factor analysis.
    Vehreschild MJ; Weitershagen D; Biehl LM; Tacke D; Waldschmidt D; Töx U; Wisplinghoff H; Von Bergwelt-Baildon M; Cornely OA; Vehreschild JJ
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):823-8. PubMed ID: 24607558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder.
    Ramanathan S; Johnson S; Burns SP; Kralovic SM; Goldstein B; Smith B; Gerding DN; Evans CT
    Am J Infect Control; 2014 Feb; 42(2):168-73. PubMed ID: 24485372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England.
    Wilcox MH; Shetty N; Fawley WN; Shemko M; Coen P; Birtles A; Cairns M; Curran MD; Dodgson KJ; Green SM; Hardy KJ; Hawkey PM; Magee JG; Sails AD; Wren MW
    Clin Infect Dis; 2012 Oct; 55(8):1056-63. PubMed ID: 22784871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile infection in children: a comprehensive review.
    Pant C; Deshpande A; Altaf MA; Minocha A; Sferra TJ
    Curr Med Res Opin; 2013 Aug; 29(8):967-84. PubMed ID: 23659563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cohorting patients with Clostridium difficile infection on risk of symptomatic recurrence.
    Islam J; Cheek E; Navani V; Rajkumar C; Cohen J; Llewelyn MJ
    J Hosp Infect; 2013 Sep; 85(1):17-21. PubMed ID: 23910403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of first recurrence of Clostridium difficile infections in children.
    Tschudin-Sutter S; Tamma PD; Milstone AM; Perl TM
    Pediatr Infect Dis J; 2014 Apr; 33(4):414-6. PubMed ID: 24168983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors, preemptive therapy, and antiperistaltic agents for Clostridium difficile infection in cancer patients.
    Krishna SG; Zhao W; Apewokin SK; Krishna K; Chepyala P; Anaissie EJ
    Transpl Infect Dis; 2013 Oct; 15(5):493-501. PubMed ID: 24034141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent Clostridium difficile infection is associated with increased mortality.
    Olsen MA; Yan Y; Reske KA; Zilberberg MD; Dubberke ER
    Clin Microbiol Infect; 2015 Feb; 21(2):164-70. PubMed ID: 25658560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive fungal infections in paediatric acute myeloid leukaemia.
    Johnston DL; Lewis V; Yanofsky R; Gillmeister B; Ethier MC; Mitchell D; Cellot S; Dix D; Portwine C; Price V; Silva M; Zelcer S; Michon B; Bowes L; Stobart K; Brossard J; Beyene J; Sung L
    Mycoses; 2013 Jul; 56(4):482-7. PubMed ID: 23437849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.